Merit Medical Systems Stock Forecast

Stock Price Forecast

The 9 analysts with 12-month price forecasts for Merit Medical Systems stock have an average target of 103.56, with a low estimate of 78 and a high estimate of 120. The average target predicts an increase of 39.64% from the current stock price of 74.16.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$78	$103.56	$106	$120
Change	+5.18%	+39.64%	+42.93%	+61.81%

Analyst Ratings

The average analyst rating for Merit Medical Systems stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26
Strong Buy	2	2	2	2	3	3
Buy	6	6	6	6	5	5
Hold	0	0	0	0	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	8	8	8	8	9	9

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Larry Biegelsen Wells Fargo	Wells Fargo	Buy → Hold Downgrades $95 → $78	Buy → Hold	Downgrades	$95 → $78	+5.18%	Feb 26, 2026
Michael Petusky Barrington Research	Barrington Research	Buy Maintains $106 → $109	Buy	Maintains	$106 → $109	+46.98%	Feb 25, 2026
Mike Matson Needham	Needham	Strong Buy Maintains $108 → $101	Strong Buy	Maintains	$108 → $101	+36.19%	Feb 25, 2026
Jason Bednar Piper Sandler	Piper Sandler	Buy Maintains $113 → $106	Buy	Maintains	$113 → $106	+42.93%	Feb 18, 2026
Sam Eiber BTIG	BTIG	Strong Buy Initiates $107	Strong Buy	Initiates	$107	+44.28%	Feb 6, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

1.65B

from 1.52B

8.78%

from 1.52B

Revenue Next Year

1.74B

from 1.65B

5.70%

from 1.65B

EPS This Year

4.14

from 2.13

94.54%

from 2.13

EPS Next Year

4.48

from 4.14

8.21%

from 4.14

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	1.07B	1.15B	1.26B	1.36B	1.52B	1.65B	1.74B
Revenue Growth	11.50%	7.09%	9.24%	7.89%	11.75%	8.78%	5.70%
EPS	0.84	1.29	1.62	2.03	2.13	4.14	4.48
EPS Growth	-	53.57%	25.58%	25.31%	4.93%	94.54%	8.21%
Forward PE	-	-	-	-	-	17.90	16.54
No. Analysts	-	-	-	-	-	14	13

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	1.7B	1.8B
Avg	1.6B	1.7B
Low	1.6B	1.6B

Revenue Growth

Revenue Growth	2026	2027
High	12.9%	11.0%
Avg	8.8%	5.7%
Low	3.6%	-0.1%

EPS Forecast

EPS	2026	2027
High	4.28	4.75
Avg	4.14	4.48
Low	3.93	4.17

EPS Growth

EPS Growth	2026	2027
High	101.1%	14.5%
Avg	94.5%	8.2%
Low	84.5%	0.5%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.